Metabolic and Immune Disease Research and Therapy Development
VeroScience is committed to developing novel, practical, and effective therapies for chronic debilitating human diseases such as Type 2 diabetes, metabolic syndrome, autoimmune disease, and cancer through interdisciplinary basic research.
Our approach at achieving these goals focuses in large part upon readjusting aberrant central nervous system (CNS) modulation of neuroendocrine activities etiologic in or supportive of these disease states.
VeroScience researchers study biological clocks in vertebrates and their organizational influence on neuroendocrine regulation of physiology to develop new treatment strategies for metabolic and immune disorders.
By investigating and mimicking nature’s means of regulating biochemical physiology for survival of vertebrates in the wild, VeroScience develops treatment strategies, not products per se, aimed at re-directing pathological biochemistry back towards its “normal” physiological organization.
“Our company is dedicated to understanding and applying nature’s genius to successfully treat human disease and thereby improve the human condition”
Anthony H. Cincotta
President and Chief Science Officer
VeroScience LLC
VeroScience has a strong pipeline of metabolic disease products and therapies for immunological disorders. VeroScience is a hybrid of academic environment mindset and industrial focus within a small and efficient organization.
The company conducts preclinical and clinical research nation-wide, utilizing strong academic and pharmaceutical industry collaborations to advance its development programs.